Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.99M | 7.17M | 8.62M | 16.97M | -27.67M |
| Total Depreciation and Amortization | 3.86M | 4.58M | 5.38M | 6.40M | 7.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.42M | -16.19M | -10.24M | -14.21M | -4.56M |
| Change in Net Operating Assets | -34.97M | -54.00M | -51.95M | -74.52M | -46.81M |
| Cash from Operations | -58.52M | -58.45M | -48.19M | -65.37M | -71.63M |
| Capital Expenditure | -228.00K | -250.00K | -127.00K | -474.00K | -1.52M |
| Sale of Property, Plant, and Equipment | 0.00 | 60.00K | 97.00K | 97.00K | 167.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 8.00M | 8.00M |
| Other Investing Activities | -275.00K | -25.00K | 7.95M | 7.93M | 7.88M |
| Cash from Investing | -503.00K | -215.00K | -76.00K | 7.55M | 6.52M |
| Total Debt Issued | 22.47M | 22.47M | 22.49M | -- | -- |
| Total Debt Repaid | -22.51M | -22.51M | -22.51M | -- | -- |
| Issuance of Common Stock | 21.08M | 50.49M | 47.38M | 43.63M | 44.78M |
| Repurchase of Common Stock | -- | -- | -- | -34.00K | -34.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.04M | 50.45M | 47.36M | 43.59M | 44.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.98M | -8.21M | -903.00K | -14.22M | -20.37M |